How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.
293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 3 |
| July 2026 | 0 | 1 |
| August 2026 | 0 | 2 |
| September 2026 | 1 | 0 |
| October 2026 | 1 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LON · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation | 293 | 240 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFUROXIME (STREP) 0.125 - 4UG/MLK052270 · LON | Becton, Dickinson & CO | 510(k) | Oct 5, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -CIPROFLOXACIN GNK052269 · LON | Becton, Dickinson & CO | 510(k) | Oct 3, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TOBRAMYCIN (GP) 0.5-16UG/MLK052250 · LON | Becton, Dickinson & CO | 510(k) | Sep 30, 2005FDA decision date |
| VITEK 2 GRAM NEGATIVE TIGECYCLINEK052311 · LON | bioMerieux, Inc. | 510(k) | Sep 29, 2005FDA decision date |
| VITEK 2 GRAM POSITIVE ERTAPENEM FOR STREPTOCOCCUS PNEUMONIAEK051849 · LON | bioMerieux, Inc. | 510(k) | Aug 16, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - DAPTOMYCIN 0.125 - 32 UG/MLK051689 · LON | Becton, Dickinson & CO | 510(k) | Aug 5, 2005FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS - RIFAMPINK051478 · LON | Dade Behring, Inc. | 510(k) | Jul 27, 2005FDA decision date |
| SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELSK051350 · LON | Dade Behring, Inc. | 510(k) | Jul 25, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMOXICILLIN (STREP) 0.0313 - 32 UG/MLK051692 · LON | Becton, Dickinson & CO | 510(k) | Jul 14, 2005FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM POSITIVE MINIMUM INHIBITORY CONCENTRATION/COMBO PANELS - LEVOFLOXACINK051311 · LON | Dade Behring, Inc. | 510(k) | Jul 12, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CLINDAMYCIN (STREP) 0.03125 -4 UG/MLK051272 · LON | Becton, Dickinson & CO | 510(k) | Jul 11, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - LINEZOLID (STREP) 0.25 - 16UG/MLK051266 · LON | Becton, Dickinson & CO | 510(k) | Jul 5, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFEPIME (STREP) 0.0625-4UG/MLK051204 · LON | Becton, Dickinson & CO | 510(k) | Jun 24, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GATIFLOXACIN (STREP) 0.0625 -8UG/MLK051183 · LON | Becton, Dickinson & CO | 510(k) | Jun 21, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN (STREP) 0.0156 - 4UG/MLK051109 · LON | Becton, Dickinson & CO | 510(k) | Jun 15, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTRIAXONE (STREP) 0.0625 - 4UG/MLK051138 · LON | Becton, Dickinson & CO | 510(k) | Jun 3, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM (STREP) 0.03125-2 UG/MLK050946 · LON | Becton, Dickinson & CO | 510(k) | May 27, 2005FDA decision date |
| BD PHONIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOTAXIME STREP (0.0625-4UG/ML)K050982 · LON | Becton, Dickinson & CO | 510(k) | May 24, 2005FDA decision date |
| VITEK 2 GRAM POSITIVE TRIMETHOPRIM/SULFAMETHOXAZOLEK050976 · LON | bioMerieux, Inc. | 510(k) | May 23, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-TRIMETHOPRIM-SULFAMETHOXAZOLE 0.0625/1.2-16/304 UG/MLK050865 · LON | Becton, Dickinson & CO | 510(k) | May 20, 2005FDA decision date |
| BD PHOENIXTM AUTOMATED MICROBIOLOGY SYSTEM - PENICILLIN (STREP) 0.156 -32 UG/MLK050780 · LON | Becton, Dickinson & CO | 510(k) | May 12, 2005FDA decision date |
| VITEK 2 GRAM POSITIVE MEROPENEMK050816 · LON | bioMerieux, Inc. | 510(k) | May 12, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TETRACYCLINE (STREP) 0.0625 - 16 UG/MLK050881 · LON | Becton, Dickinson & CO | 510(k) | May 12, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, VANCOMYCIN (STREP) 0.0625 -32 UG/MLK050745 · LON | Becton, Dickinson & CO | 510(k) | Apr 29, 2005FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, LEVOFLOXACIN (STREP) 0.25-16 UG/MLK050747 · LON | Becton, Dickinson & CO | 510(k) | Apr 29, 2005FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.